As of May 2023 ยท from BABE KOMBUCHA Convertible Note 1 ยท a SAFE/note conversion ceiling, not a priced valuation
Total raised
$437,589
Across 1 round since 2022
Latest share price
$1.00
BABE KOMBUCHA Convertible Note 1 offering price
Financials
FY2020โFY2025 ยท from SEC filings ยท hover any figure for its source
$502K
โ$106K
2020
$773K
โ$77K
2021
$773K
โ$77K
2022
$1.7M
โ$330K
2023
$1.6M
โ$982K
2024
$1.6M
โ$1.1M
2025
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$501,850
$772,822
$772,822
$1,741,310
$1,611,590
$1,554,594
Cost of goods sold
$228,864
$276,127
$276,127
$620,759
$801,540
$958,615
Gross margin
54%
64%
64%
64%
50%
38%
Net income
-$105,948
-$76,920
-$76,920
-$330,465
-$981,916
-$1,063,059
Taxes paid
$1,777
$1,860
$1,860
$7,542
$26,925
$13,353
Balance sheet
Cash
$35,461
$25,346
$25,346
$21,675
$134,593
$36,145
Accounts receivable
$7,286
$42,048
$42,048
$124,551
$51,238
$174
Total assets
$439,665
$545,486
$545,486
$589,308
$440,373
$626,628
Short-term debt
$243,743
$128,767
$128,767
$135,076
$51,420
$71,551
Long-term debt
$126,013
$235,404
$235,404
$907,623
$2,043,276
$1,565,389
Total liabilities
$369,756
$364,171
$364,171
$1,042,699
$2,094,696
$1,636,940
Other
Headcount
โ
8
โ
8
7
7
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.